HPV Comes to Zhengzhou

　　Female friends from 20 to 45 years old who needs HPV vaccines could go to Wellcare Community Hospital and get the service. “Wellcare Community Hospital” begins to accept an appointment on November 25 with the appointment call 86561607. The address is on the third floor of Zhengzhou Wellcare Community Hospital (the interchange of Kang Ping Road and Yulin North Street).

　   Quadrivalent human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer.They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.

　　The World Health Organization recommends HPV vaccines as part of routine vaccinations in all countries, along with other prevention measures. The vaccines require two or three doses depending on a person's age and immune status. Vaccinating girls around the ages of nine to thirteen is typically recommended. The vaccines provide protection for at least 5 to 10 years. Cervical cancer screening is still required following vaccination. Vaccinating a large portion of the population ma0y0=so benefit the unvaccinated. In those already infected the vaccines are not effective.

　　It is understood that Zhengzhou is the second city after Chongqing which introduces Recombinant Human Papillomavirus Quadrivalent Vaccine.

　　Age suitable for vaccination is from 20 to 45 years old. This medicine can prevent more HPV infection, not only reducing the risk of cervical cancer, but also preventing common venereal diseases and skin diseases. Its price is 820 yuan each. As required, the user should have the injection for 3 times in total.

　　In China, cervical cancer is the cancer ranking behind only breast cancer with high frequency.